Shiraiwa; Hirotake
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shiraiwa; Hirotake.The latest application filed is for "antibody molecules".
Company Profile
5.23.39
- Shiraiwa; Hirotake - Shizuoka JP
- Shiraiwa; Hirotake - Tokyo JP
Patent Activity
| Patent | Date |
|---|---|
| Antibody Molecules App 20220306755 - Igawa; Tomoyuki ; et al. | 2022-09-29 |
| Modified Antibody Constant Region App 20220251225 - Igawa; Tomoyuki ; et al. | 2022-08-11 |
| Antigen-binding Molecule Containing Two Antigen-binding Domains That Are Linked To Each Other App 20220195045 - SHIRAIWA; Hirotake ; et al. | 2022-06-23 |
| Modified antibody constant region Grant 11,332,533 - Igawa , et al. May 17, 2 | 2022-05-17 |
| Antigen-binding Molecule Comprising Altered Antibody Variable Region App 20220112296 - Igawa; Tomoyuki ; et al. | 2022-04-14 |
| Antibody Constant Region Variant App 20220064264 - Igawa; Tomoyuki ; et al. | 2022-03-03 |
| Antibody Molecules App 20220041741 - Igawa; Tomoyuki ; et al. | 2022-02-10 |
| Cytotoxicity-inducing Therapeutic Agent App 20210230311 - NEZU; Junichi ; et al. | 2021-07-29 |
| Anti-il-6 Receptor Antibody App 20210206862 - Igawa; Tomoyuki ; et al. | 2021-07-08 |
| Cytotoxicity-inducing therapeutic agent Grant 11,001,643 - Nezu , et al. May 11, 2 | 2021-05-11 |
| Heterodimerized polypeptide Grant 10,766,960 - Igawa , et al. Sep | 2020-09-08 |
| Antibody Molecules App 20200231688 - Igawa; Tomoyuki ; et al. | 2020-07-23 |
| Methods of reducing IL-6 activity for disease treatment Grant 10,662,245 - Igawa , et al. | 2020-05-26 |
| Anti-nr10 Antibody And Use Thereof App 20200002429 - Kuramochi; Taichi ; et al. | 2020-01-02 |
| Antibody Constant Region Variant App 20190211081 - Igawa; Tomoyuki ; et al. | 2019-07-11 |
| Antibody constant region variant Grant 10,253,091 - Igawa , et al. | 2019-04-09 |
| Anti-il-6 Receptor Antibody App 20190085085 - Igawa; Tomoyuki ; et al. | 2019-03-21 |
| Antibody constant region variant Grant 10,066,018 - Igawa , et al. September 4, 2 | 2018-09-04 |
| Cytotoxicity-inducing Therapeutic Agent App 20180244805 - NEZU; Junichi ; et al. | 2018-08-30 |
| Heterodimerized Polypeptide App 20180155451 - Mimoto; Futa ; et al. | 2018-06-07 |
| Cytotoxicity-inducing theraputic agent Grant 9,975,966 - Nezu , et al. May 22, 2 | 2018-05-22 |
| Heterodimerized polypeptide Grant 9,890,218 - Mimoto , et al. February 13, 2 | 2018-02-13 |
| Modified Antibody Constant Region App 20170342154 - Igawa; Tomoyuki ; et al. | 2017-11-30 |
| Cytotoxicity-Inducing Therapeutic Agent App 20170267783 - NEZU; Junichi ; et al. | 2017-09-21 |
| Modified antibody constant region Grant 9,688,762 - Igawa , et al. June 27, 2 | 2017-06-27 |
| Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient App 20170129950 - SHIRAIWA; Hirotake ; et al. | 2017-05-11 |
| Anti-IL-6 Receptor Antibody App 20170121412 - Igawa; Tomoyuki ; et al. | 2017-05-04 |
| Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient Grant 9,556,264 - Shiraiwa , et al. January 31, 2 | 2017-01-31 |
| Nucleic acids encoding anti-NR10 antibodies Grant 9,399,680 - Kuramochi , et al. July 26, 2 | 2016-07-26 |
| Antibody Constant Region Variant App 20160159915 - Igawa; Tomoyuki ; et al. | 2016-06-09 |
| Anti-AXL antibody Grant 9,340,615 - Maeda , et al. May 17, 2 | 2016-05-17 |
| Antibody constant region variant Grant 9,228,017 - Igawa , et al. January 5, 2 | 2016-01-05 |
| Heterodimerized Polypeptide App 20150344570 - Igawa; Tomoyuki ; et al. | 2015-12-03 |
| Anti-Glypican-3 Antibody Having Improved Kinetics in Plasma App 20150315278 - IGAWA; Tomoyuki ; et al. | 2015-11-05 |
| Antibody Constant Region Variant App 20150274809 - Igawa; Tomoyuki ; et al. | 2015-10-01 |
| Anti-nr10 Antibody And Use Thereof App 20150175704 - Kuramochi; Taichi ; et al. | 2015-06-25 |
| Antibody Molecules That Bind To Il-6 Receptor App 20150166666 - Igawa; Tomoyuki ; et al. | 2015-06-18 |
| Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient App 20150110793 - Shiraiwa; Hirotake ; et al. | 2015-04-23 |
| Heterodimerized Polypeptide App 20140199294 - Mimoto; Futa ; et al. | 2014-07-17 |
| Anti-nr10 Antibody And Use Thereof App 20140039165 - Kuramochi; Taichi ; et al. | 2014-02-06 |
| Anti-IL-6 Receptor Antibody App 20130317203 - Igawa; Tomoyuki ; et al. | 2013-11-28 |
| Anti-glypican-3 Antibody Having Improved Kinetics In Plasma App 20130295612 - IGAWA; Tomoyuki ; et al. | 2013-11-07 |
| Anti-NR10 antibody and use thereof Grant 8,575,317 - Kuramochi , et al. November 5, 2 | 2013-11-05 |
| Antibody molecules that bind to IL-6 receptor Grant 8,562,991 - Igawa , et al. October 22, 2 | 2013-10-22 |
| Anti-glypican-3 antibody having improved kinetics in plasma Grant 8,497,355 - Igawa , et al. July 30, 2 | 2013-07-30 |
| Antibody Molecules That Bind To Il-6 Receptor App 20120253016 - Igawa; Tomoyuki ; et al. | 2012-10-04 |
| Anti-axl Antibody App 20120121587 - Maeda; Atsuhiko ; et al. | 2012-05-17 |
| Antibody Constant Region Variant App 20120071634 - Igawa; Tomoyuki ; et al. | 2012-03-22 |
| Antibody Constant Region Variant App 20120065379 - Igawa; Tomoyuki ; et al. | 2012-03-15 |
| Anti-IL-6 Receptor Antibody App 20110245473 - Igawa; Tomoyuki ; et al. | 2011-10-06 |
| Anti-nr10 Antibody And Use Thereof App 20110229459 - Kuramochi; Taichi ; et al. | 2011-09-22 |
| Anti-nr10 Antibody And Use Thereof App 20110129459 - Kuramochi; Taichi ; et al. | 2011-06-02 |
| Antibody Molecules App 20110098450 - Igawa; Tomoyuki ; et al. | 2011-04-28 |
| Modified Antibody Constant Region App 20100298542 - Igawa; Tomoyuki ; et al. | 2010-11-25 |
| Anti-glypican-3 Antibody Having Improved Kinetics In Plasma App 20100239577 - Igawa; Tomoyuki ; et al. | 2010-09-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 